As per Future Market Insights’ (FMIs’) latest revised industry analysis, the global Gamma Probe Devices Market was valued at over US$ 72.4 Mn in 2020, and is expected to exhibit a CAGR of close to 9.5% over the forecast period (2021-2031).
Gamma probe devices aid surgeons in identifying radio-labeled tissue prior to surgery for radio guided analysis, diagnosis, and operations. Surgeons frequently struggle to discover tissues within the human body, such as malignancies, parathyroid glands, and lymph nodes. As a result, appropriate use of a gamma probe device allows the medical expert to make a smaller incision even while locating the tissues of interest.
The rising number of thyroid and breast cancer disease patients and increasing preference for non-invasive procedures, owing to lesser hospital stay and cost effective solution also will drive the gamma probe devices market.
Request a report sample to gain comprehensive insights at https://www.futuremarketinsights.com/reports/sample/REP-GB-10037
Most minimally invasive surgical procedures require gamma probe devices. Innovation in gamma probe devices and better patients outcomes in minimally invasive surgical procedures using gamma probe devices are also expected to boost the market growth.
The increasing preference for image guided procedures and recent advancements in gamma probe devices with low cost facility are also projected to favor the market growth over the forecast period.
Gamma probe devices are increasingly being used in sentinel lymph node mapping in breast cancer and parathyroid surgery. As per WHO, 2.3 million women were diagnosed with cancer of breast while 685 thousand deaths happened due to the same reason in 2020.
As per Cancer research organization of the U.K, breast cancer is the fourth most common cause of cancer death in the UK, accounting about seven percent of all cancer deaths. Diseases such as breast cancer can be preventable if patients are diagnosed at an early stage.
However, till now, only few key players such as Hologic Inc., Danaher, BIODEX, and Southern Scientific Ltd. are actively involved in manufacturing of gamma probe devices, which will create huge opportunities for other small as well as big manufacturers to enter the gamma probe devices market.
For any Queries Related with the Report, Ask an Analyst@ https://www.futuremarketinsights.com/ask-question/rep-gb-10037
Key Takeaways from Market Study
- The trolley mounted device segment accounted for the highest share of approx. 1% in 2021 owing to a rise in demand from hospitals because of convenience factor, i.e. easy operability and less cost.
- The use of a gamma probe device resulted in a higher SLN detection rate, more accurate SLNB site identification (axillary or extra-axillary sites), and fewer problems which leads to account for largest share for more than 56% in the application segment.
- The hospitals segment dominates the gamma probe devices market with over 52.8% value share in 2021, owing to the increasing need for gamma probe devices in critical care units for breast and thyroid cancer procedures.
- Europe accounts for the highest share for approximately 43.5% of the global gamma probe devices market share in 2021, due to the increasing breast cancer mortality rate in this region.
“Increasing prevalence of breast cancer and surging awareness among the people about the benefits of gamma radiation in various treatment will boost the market over the forecast period” says an analyst at FMI.
Who is winning?
The market for gamma probe devices is relatively consolidated. In this industry, there are several participants, with Hologic, LabLogic Group Holdings, and Danaher Corporation being the most prominent. These companies have strong product portfolios, product innovation, and business strategies that are cutting-edge.
These major market players have pursued a wide range of business approaches, including strategic partnerships with other medical device companies for product marketing and services, as well as collaboration with healthcare institutions for advanced technology research and development.
- In August 2020, Hologic announced a collaboration with RadNet towards the development of artificial intelligence tools in breast health.
In December 2019, Mammotome, a subdivision of Danahera Diagnostics, unveiled a new brand identity with an updated look and feel. Mammotome also began distribution of the TruCore™ II automatic core biopsy instrument in various regions.
We Offer tailor-made Solutions to fit Your Requirements, Request Customization @ https://www.futuremarketinsights.com/customization-available/rep-gb-10037
Explore FMI’s Extensive ongoing Coverage on Healthcare Domain
Gamma Glutamyl Transferase Testing Market – Gamma glutamyl transferase testing involves the quantitative assessment of gamma glutamyl transferase. This is a membrane protein which catalyze the transfer of glutamyl to amino acids or peptides.
Orthopedic Prosthetic Devices Market – The orthopedic prosthetic devices market is projected to register a CAGR of 4.7% during the forecast period, up from US$ 1.9 Bn in 2019 to reach a valuation of US$ 2.8 Bn by 2027.
Cardiovascular Prosthetic Devices Market – The global cardiovascular prosthetic devices market is expected to grow at a CAGR of 8.20 % during the forecast year 2022 to 2032, up from US$ 5.15 Bn in 2021 to US$ 9.71 Bn by 2028.
About Future Market Insights (FMI)
Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, and has delivery centers in the UK, U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.
Future Market Insights,
1602-6 Jumeirah Bay X2 Tower,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
For Sales Enquiries: firstname.lastname@example.org